fda import alert 66-80 glp-1 green list Issues on GLP-1s Following Launch of “Green List” FDA creates "green list" to
Description
J Gen Intern Med 24(1):129131 Kamata Y, Takano K, Kishihara E, Watanabe M, Ichikawa R, Shichiri M (2017) Distinct clinical characteristics and therapeutic modalities for diabetic ketoacidosis in type 1 and type 2 diabetes mellitus
doi: 10.1186/s13054-025-05516-2 58

Month-on-month incremental consumption in the injections market stood at 8.91 thousand units in November 2025 and 8.75 thousand units in December
The GLP-1 fibers and TPH positive neurons were visualized with a confocal microscope (LSM 700
Many patients achieve this within approximately 1.53 months, depending on adherence and dosing

These drugs are also used to reduce the risk of heart disease and kidney damage
